Ascend Wellness Holdings AAWH
OTC AAWH
$0.48 +0.02 (+5.47%)
As of: Aug 21, 2026 · 3:59 PM EDT

Ascend Wellness Holdings (AAWH) Liabilities and Shareholders Equity (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Liabilities and Shareholders Equity of $872.1 million for Q1 2026, down 4.87% year-over-year from $916.7 million in Q1 2025, and down 3.95% quarter-over-quarter from $907.9 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $872.1 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 4.87% year-over-year to $872.1 million; the TTM figure through Mar 2026 stood at $2.7 billion (down 26.3% YoY), while the FY2025 annual figure was $907.9 million, up 0.83% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $872.1 million, down from $907.9 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $929.4 million in Q2 2024, with the low at $407000.0 in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $899.6 million (2023), against an average of $829.9 million.
  • The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity surged 48.39% in 2022, then plunged 99.95% in 2025.
  • Ascend Wellness Holdings' Liabilities and Shareholders Equity stood at $872.2 million in 2022, then increased by 5.43% to $919.6 million in 2023, then retreated by 2.08% to $900.4 million in 2024, then grew by 0.83% to $907.9 million in 2025, then declined by 3.95% to $872.1 million in 2026.
  • Business Quant data shows AAWH's Liabilities and Shareholders Equity at $872.1 million in Q1 2026, $907.9 million in Q4 2025, and $407000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 39.86 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 6.18 Bn
10 Ascend Wellness Holdings 97.42 Mn 30.42 Mn 45.49 Mn 888.32 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 888.32 Mn
Mar 31, 2026 872.09 Mn
Dec 31, 2025 907.93 Mn
Sep 30, 2025 407,000.00
Jun 30, 2025 903.87 Mn
Mar 31, 2025 916.73 Mn
Dec 31, 2024 900.43 Mn
Sep 30, 2024 895.87 Mn
Jun 30, 2024 929.36 Mn
Mar 31, 2024 921.86 Mn
Dec 31, 2023 919.55 Mn
Sep 30, 2023 907.99 Mn
Jun 30, 2023 899.56 Mn
Mar 31, 2023 870.09 Mn
Dec 31, 2022 872.16 Mn
Sep 30, 2022 847.21 Mn
Jun 30, 2022 828.79 Mn
Mar 31, 2022 714.20 Mn
Dec 31, 2021 723.44 Mn
Sep 30, 2021 716.88 Mn